‘Fat Activists’ Oppose Ozempic for the Wrong Reasons

They are against drugs like Ozempic because they wrongly view fatness as an identity. But we should be wary of treating drugs as the only solution to obesity.

Share this story

Boxes of Ozempic and Mounjaro, semaglutide and tirzepatide injection drugs used for treating type 2 diabetes and made by Novo Nordisk and Lilly, is seen at a Rock Canyon Pharmacy in Provo, Utah, March 29, 2023.

George Frey/Reuters

Weight-loss drugs might be revolutionizing how we treat obesity. But one group is standing athwart this potential progress, yelling, “No thanks!”: the overweight.

Not all overweight people think this way, to be sure. It’s a subset who have, in recognizably left-wing fashion, adopted adiposity as an oppressed identity. While their opposition has a weak core, there are other, more legitimate reasons to be skeptical of GLP-1 drugs such as Ozempic and Wegovy — reasons that are free of leftist adulteration. For one, there are healthier, safer, and more lasting ways to lose weight.

Jack Butler

About the Author

Jack Butler

Jack Butler is a former submissions editor at National Review.

Comments

Advertisement

Advertisement